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Abstract
Background: Health record-based observations from several parts of Africa indicate a major
decline in malaria, but up-to-date information on parasite prevalence in West-Africa is sparse. This
study aims to provide parasite prevalence data from three sites in the Gambia and Guinea Bissau,
respectively, and compares the usefulness of PCR, rapid diagnostic tests (RDT), serology and slide-
microscopy for surveillance.
Methods: Cross-sectional surveys in 12 villages at three rural sites were carried out in the Gambia
and Guinea Bissau in January/February 2008, shortly following the annual transmission season.
Results: A surprisingly low microscopically detectable parasite prevalence was detected in the
Gambia (Farafenni: 10.9%, CI95%: 8.7-13.1%; Basse: 9.0%, CI95%: 7.2-10.8%), and Guinea Bissau
(Caio: 4%, CI95%: 2.6-5.4%), with low parasite densities (geometric mean: 104 parasites/μl, CI95%:
76-143/μl). In comparison, PCR detected a more than three times higher proportion of parasite
carriers, indicating its usefulness to sensitively identify foci where malaria declines, whereas the
RDT had very low sensitivity. Estimates of force of infection using age sero-conversion rates were
equivalent to an EIR of approximately 1 infectious bite/person/year, significantly less than previous
estimates. The sero-prevalence profiles suggest a gradual decline of malaria transmission,
confirming their usefulness in providing information on longer term trends of transmission. A
greater variability in parasite prevalence among villages within a site than between sites was
observed with all methods. The fact that serology equally captured the inter-village variability,
indicates that the observed heterogeneity represents a stable pattern.
Conclusion: PCR and serology may be used as complementary tools to survey malaria in areas of
declining malaria prevalence such as the Gambia and Guinea Bissau.
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Background
Although still considered a major international health
problem, accumulating evidence indicates that malaria
caused by Plasmodium falciparum may be on the decline in
parts of sub-Saharan Africa. Longitudinal health record-
based datasets have recently indicated a significant reduc-
tion of the burden of disease in the Gambia [1], in Kenya
[2,3] and Eritrea [4] occurring over the last decade.
In February 2008, the Gambian Government launched a
policy that malaria should be eliminated as a public
health problem. The effectiveness of such efforts needs to
be monitored carefully requiring an adequate surveillance
system. It has already been recognized that dependent on
the aim (control or elimination) and transmission inten-
sity different surveillance methods are likely to be needed
[5]. Deriving estimates for prevalence and transmission of
malaria from health centre records is unreliable: asympto-
matic parasite carriers or cases occurring in communities
with difficult access to health care may be missed [6],
while common over-diagnosis of malaria [7] results in
gross overestimation of the true number of cases, particu-
larly in areas of low transmission [8]. Where elimination
is the goal, surveillance should measure the prevalence of
the causative agent of the disease directly rather than dis-
ease incidence. Thus, sensitive methods to determine par-
asite prevalence and exposure are required, ideally at the
community level. The gold standard for detection of
malaria parasites still remains slide microscopy, but it is
known for long that a substantial proportion of individu-
als in a community may have low density infections
below the microscopic detection threshold [9]. Such sub-
microscopic infections contribute substantially to the
infectious reservoir [10,11], as they are well capable to
infect mosquitoes [12]. Thus, surveillance that aims at
identifying the last parasite carrier, requires more sensitive
tools such as polymerase chain reaction (PCR) capable to
identify as few as 1-10 parasites/μl [13,14]. A recent meta-
analysis of studies where parasite prevalence was meas-
ured by both PCR and microscopy found that microscopy
only detects about 50% of the parasite carriers detected by
PCR, and points out that this percentage decreases even
further with decreasing transmission [15].
Although surveillance is defined as an ongoing continu-
ous collection of data [16], for practical reasons, monitor-
ing parasite prevalence commonly relies on repeated
cross-sectional surveys. Here, the fact that in many areas
like the Gambia malaria transmission is highly seasonal
constitutes another challenge, as parasite prevalence will
vary greatly depending on the timing of data collection.
Additional means providing information on exposure
over time, ideally allowing the assessment of mid-term
trends independent of seasonal variations are highly
desirable. In recent years, age-stratified sero-prevalence
data of anti-malarial antibodies has been suggested as a
useful tool for this purpose [17-19] and may hold partic-
ular promise for areas with low malaria transmission: due
to the longevity of antibody responses, sero-prevalence
data are expected to be higher than parasite rates from
cross-sectional surveys and may thus offer a higher sensi-
tivity, and less susceptibility to seasonal fluctuations in
transmission. High antibody levels in geographically
defined areas may direct targeted control measures and
reduction in antibody levels indicate the success of inter-
ventions.
Taken together, these considerations indicate the need to
employ further tools in addition to or instead of slide
microscopy to fully capture parasite prevalence and trans-
mission dynamics at the community level in areas where
malaria appears to be on the decline.
The aim of this study was to obtain up to date information
on P. falciparum malaria parasite prevalence in the Gam-
bia and Guinea Bissau, and to validate the usefulness of
PCR, and serology as tools to monitor malaria endemicity
in comparison to slide microscopy, and rapid diagnostic
tests (RDT). To this end, cross-sectional surveys were car-
ried out in 12 villages at three different sites enrolling a
total of 2659 individuals at the end of the malaria trans-
mission in January/February 2008.
Methods
Survey procedures
Consecutive cross-sectional surveys were carried out in the
Gambia shortly after the end of the malaria transmission
season 2008 in the areas around Basse (9th - 15th January),
and Farafenni (31st Jan - 7th Feb), and in Guinea Bissau, in
the area around Caio (19th - 28th Feb), where the MRC
supports a research laboratory. In both countries, malaria
transmission is highly seasonal, occurring from August till
January, with a peak in November. The study sites have
been described in detail elsewhere [20-22]. Based on
information from local demographic surveys four villages
of appropriate population size were selected at each site
that would have at least 45 inhabitants in each of the age
groups specified below. After an initial sensitization,
those who were willing to participate were grouped
according to age, based on the available census data into
the following age groups: < 5 years; 5-10; > 11-15; 16-25;
26-40; >40 years. In an attempt to avoid household clus-
tering, all volunteers in each group received consecutive
numbers, and the total number of volunteers per group
was noted, out of which a random numbers generator
drew 45 numbers that identified the participants. Where
less than 45 people volunteered per age group, all were
enrolled. After written consent was obtained, a question-
naire was administered, approximately 300 μl of blood
were obtained by finger prick, and the Hackett score wasMalaria Journal 2009, 8:274 http://www.malariajournal.com/content/8/1/274
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assessed by a clinician for children aged 1-15 years in all
but two villages (S and W). In total, 2,659 people were
enrolled (see Additional file 1 for details). The study was
reviewed and approved by the Joint Gambian Govern-
ment/MRC Ethics Committee, as well as the Comité Ético
do MINSA, Bissau.
Assessment of parasite prevalence
Thick blood films were performed in the field and
Giemsa-stained in MRC laboratory facilities at Farafenni,
Basse and Caio. Slides were examined for the presence of
P. falciparum malaria parasites by an experienced micro-
scopist, reading 100 high power fields (×1,000) under oil
immersion. 10% of slides were read twice as a quality
check. An RDT for malaria (OptiMAL) was performed on
site, following the manufacturer's instructions. The
remaining sample was stored into an EDTA K2 (BD Micro-
tainer Systems, UK) tube. Blood was separated by centrif-
ugation (1,500 rpm, 7 min at RT) into plasma and red
blood cells which were subsequently stored separately at -
20°C. Upon completion of the survey, DNA was extracted
from the pellets using a Corbett Robotics X-Trator Gene™
(Corbett Research Pty Ltd, Australia), and detection of
parasite DNA was performed based on nested PCR ampli-
fication of the multi-copy 18s rRNA gene as previously
described [14]. Positive controls consisting of parasite
DNA and a negative control consisting of DNA extracted
from malaria-negative blood were included in each PCR
run.
Anti-MSP-119 ELISA
IgG antibody levels binding to MSP-119, (Wellcome
allele), fused to glutathione S transferase were measured
by indirect ELISA as described [23]. Sera were tested at a
single dilution (1:1,000) that has been evaluated previ-
ously in the Gambian setting [24].
Statistics
Taking the age stratified nature of the data into account
estimates for the parasite prevalence in the population at
each site were calculated as weighted averages of the slide
microscopy results in the study population based on the
age distribution in each of the villages. To model malaria
endemicity based on malarial antibody responses, a
reversible catalytic conversion model was fitted to the
measured MSP-119 sero-prevalence data from each site
stratified into age groups by using standard maximum
likelihood methods, based on a binomial error distribu-
tion, as described [17,18]. This provides an estimate of the
mean annual rate of conversion to seropositive (sero-con-
version rate = N), averaged over the age of the population.
To exclude the impact of maternally derived antibodies in
infants, individuals below 12 month were excluded. To
investigate the possibility of sudden changes in transmis-
sion (for example due to implementation of highly effi-
cient control measures), further models were fitted in
which N was allowed to change at a single time points dur-
ing the past 30 years [19]. Likelihood ratio tests against
models with fixed N were used to determine whether there
was a significant change in sero-conversion rate. Based on
previous estimates [17] a fixed rate of reversion from sero-
positive to seronegative was fitted (N = 0.0173/year).
To investigate the potential differences in parasite or sero-
prevalence within and between sites, separate mixed effect
models were fitted for i) parasitaemia assessed by slide
microscopy, ii) by PCR, and iii) for anti-MSP-119 antibod-
ies, allowing for the clustering between sites. Initially, var-
iables that were likely to be associated or had already been
shown to be associated with malaria prevalence in univar-
iable analysis, such as age, gender, village, ethnicity and
bed net use were included in the model. Subsequently,
only variables with p-values < 0.05 were kept in the
model, which applied to age and gender. In a second step
possible additional risk factors such as ethnicity and bed
net use were adjusted for.
Results
Low malaria prevalence in Gambia and Guinea Bissau
The cross-sectional surveys of malaria prevalence
described here, carried out in January/February 2008,
shortly after the end of the malaria transmission season
showed that the parasite prevalence assessed by slide
microscopy for those enrolled into the survey was 11.2%
(CI 95%. 9.2-13.7%) in Farafenni, 10.4% (CI 95%: 8.6-
12.5%) in Basse, and 4% (CI 95%: 2.8-5.5%) in Caio.
Taking the age distribution at each village into account,
the estimated parasite prevalence in the population in
Farafenni, Basse and Caio is 10.9% (CI 95% 8.7-13.1%),
9.0% (CI95%: 7.2-10.8%), and 4% (CI95%: 2.6-5.4%),
respectively. Compared to data from similar surveys car-
ried out in the past [20,22,25-34], these are amongst the
lowest parasite prevalence data ever reported for Basse
and Farafenni. However, considering that malaria trans-
mission in the study area is seasonal, direct comparison to
historical data is limited by the fact that surveys were car-
ried out at different times of the year. Whilst the survey
presented here was conducted shortly after the end of the
transmission season, in Jan/Feb, previously published
surveys from Basse [20,25,33] and Farafenni
[22,27,28,30,31,34] report data from the peak of the
transmission season (Nov), and - in the case of Farafenni
- from the middle [26] or the end of the dry season
[27,31,34]. However, it is noteworthy that the parasite
prevalence measured in Jan/Feb 2008 in the Farafenni
area is considerably lower than data obtained in previous
years during the dry season (March 82 [26], May 86 [31],
June 89 [27], June 90 [34]). In Caio, a rural area of Guinea
Bissau, parasite prevalence in Feb 2008 was considerably
lower than measured in this area in October 1990 andMalaria Journal 2009, 8:274 http://www.malariajournal.com/content/8/1/274
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1991 [32], and similarly low as described in an urban area
of Guinea Bissau in 2003 [35] (Figure 1). Demographic
data are presented in Additional file 1.
When parasite prevalence was assessed by qualitative
PCR, a three-fold higher percentage (25.5%; CI 95%: 23-
7 - 27.3%) of the study population tested positive. The
microscopy: PCR prevalence ratio is thus 0.33, indicating
that parasite prevalence detected by microscopy is 66%
lower than that detectable by PCR.
The RDT detected 8 fold (22 fold) less parasite carriers
(1.1% CI 95%: 0.8 - 1.6%) compared to slide microscopy
(and PCR; Table 1, 2 and 3). When tested with blood
spiked with known concentrations of P. falciparum in our
laboratory, the detection limit of the RDT was between
140 to 1,400 parasites/μl (D. Nwakanma, unpublished),
which is consistent with previous reports indicating con-
siderable loss of sensitivity at levels below 500/μl [36].
Only 14/1,093 children examined had an enlarged
spleen, with 57% of them being in village 'T' which had
the highest infection prevalence.
Sero-prevalence of anti MSP-119 antibodies increases 
continuously with age
Antibodies against MSP-119 were measured by ELISA and
their sero-prevalence plotted according to age for each
study site (Figure 2A-C). Sero-prevalence increased at all
sites continuously with age. As described in the methods,
data from each site were used to fit a model that calculates
a fixed sero-conversion rate N(SCR), which is related to the
'force of infection' of malaria [37]. EIR estimates derived
from SCR ranged from 0.4 to 4 in the two Gambian sites
and 0.2 to 0.5 in Caio. To explore whether sudden
changes in transmission (for example due to implementa-
tion of highly efficient control measures) have occurred,
further models were fitted in which λ was allowed to
change at a single time point ("step-model") [19]. How-
ever, for all study sites, likelihood ratio tests comparing
the step-models to those with fixed N, failed to identify a
significant change in sero-conversion rates, suggesting
that no sudden decline in transmission has occurred. For
one of the villages surveyed in Farafenni samples collected
in 1988 were analysed previously using the same ELISA
protocol [38]. The estimate for the EIR based on serologi-
cal parameters [17] was four in 1988, and one in 2008,
adding support to the notion of a gradual decline. Subse-
quently, a model was examined in which the force of
infection was allowed to decrease linearly over a 20 -year
period. However, the fit was poor suggesting that this sim-
ple linear reduction was an oversimplification.
Figure 2D illustrates a significant positive correlation
between sero-conversion rate and microscopic parasite
prevalence over the 12 villages (Correlation coefficient:
0.73, p = 0.0072). Village D does not fit this trend, as par-
asite prevalence was relatively high despite a moderate N,
which might be explained by very recent malaria exposure
that has not yet resulted in increased antibody responses.
Removing this value enhances the fit (correlation coeffi-
cient: 0.91, p = 0.0001).
Greater variability in malaria prevalence found within 
study sites than between
In Figure 3, the prevalence of malaria parasitaemia is
shown for each of the surveyed villages as assessed by A)
slide microscopy or B) PCR. Data for C) sero-prevalence
of anti MSP-119 antibodies and D) spleen rates are dis-
played in a similar way. For all shown parameters, there is
considerable variation between villages within a study
site, but less variability between study sites. Using mixed
effect models adjusting for age and sex and applied to
either slide results, PCR or sero-prevalence data there was
no clustering by study site (p = 0.26 [slide], p = 0.21
[PCR], and p = 0.22 [sero-prevalence]), indicating that the
variation of malaria prevalence between study sites is not
significant.
However, significant inter-village variability was observed
for parasite prevalence assessed by slide microscopy in all
sites (p < 0.0001 [Basse], p = 0.01 [Farafenni], p = 0.05
[Caio]), and by PCR in Basse (p < 0.0001) and Caio (p =
0.03). Likewise, significant inter-village variability was
noted for sero-prevalence in Basse (p < 0.0001) and Faraf-
enni (p < 0.0001). Even after additional adjusting for bed
net usage and ethnicity, variability for parasite prevalence
within a study site remained significant in Basse (p =
0.001) when assessed by slide reading, and in Basse (p =
0.0002) and Caio (p = 0.02) when assessed by PCR, while
the variability for sero-prevalence remained significant in
Basse (p < 0.0001) and Farafenni (p < 0.0001). However,
since the association of village and malaria prevalence or
sero-positivity was highly confounded with ethnicity (see
Additional file 1) with some ethnicities (Manjago, Wolof,
Serehule) exclusively resident in one site the effect of eth-
nicity could only be adjusted for partially.
Peak of parasite prevalence shifts to adolescence
Analysis of parasite prevalence detected by PCR (Figure
4A) or slide microscopy (Figure 4B) revealed a significant
linear increase with age (test for trend: p < 0.0001 [PCR],
p = 0.004 [slide]), peaking in the group of 11-15 years old,
followed by a decline in older age groups. Parasite density
(4B) dropped significantly with age until adolescence (p <
0.0001) thereafter remaining at low levels (p = 0.3).
For a village at the Farafenni site age-stratified parasite
prevalence and density data from October 1988 have been
published [38]. Comparison of these data (Figure 4C) toMalaria Journal 2009, 8:274 http://www.malariajournal.com/content/8/1/274
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Current and previous malaria parasite prevalence data from Basse, Farafenni and Caio Figure 1
Current and previous malaria parasite prevalence data from Basse, Farafenni and Caio. Data from our survey are 
presented alongside historical data extracted from published reports from A) Basse area, B) Farafenni area or C) Guinea Bis-
sau. Where information on parasite densities was available, percentage of people with 1-4999 and ≥5000 parasites/μl is shown 
in white and grey blocks, respectively; where parasite densities were not reported, parasitaemia rates are shown as hatched 
bars. Bars show percentages with 95% CI. Information on age groups surveyed, bed net coverage and the reference are pro-
vided in a tabulated format underneath each bar. To enhance comparability our results are displayed for similar age groups as 
those predominantly reported for this area previously.
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results from the survey in this study (Figure 4D) suggests
that the parasite prevalence and parasite densities meas-
ured in 2008 are substantially lower than those deter-
mined in 1988.
Bed net use in children under five year of age reduces 
parasite prevalence measured by slide but not by PCR
When parasite prevalence assessed by slide microscopy
was compared between people sleeping under a bed net
(61.9%) and those who didn't, overall bed net-usage had
a protective effect with regard to microscopic parasite
prevalence (OR 0.63, CI95%: 0.47-0.83, p = 0.001). Espe-
cially, children not using a net had a 3.3 fold (0 to 5 years,
p < 0.001), and 1.7 fold (6-10 years; p = 0.06) higher par-
asite prevalence (Figure 5A). For children under the age of
five years, the association between bed net use and lower
parasite prevalence assessed by microscopy was still sig-
nificant after adjusting for gender, village, ethnicity and
area (OR 0.33, CI95%: 0.16-0.68, p = 0.003), but became
non significant in older age groups. This confirms the
expected protective effect of bed nets, particularly in the
under-five year age group, who belong to the main target
population for bed net use. Anti-MSP-119 sero-prevalence
for under five year olds sleeping under a bed net was half
of that observed for children not using bed nets (p =
0.003, Figure 5C; after adjusting for gender, village, eth-
nicity and area: OR: 0.53 CI95%: 0.29-0.96, p = 0.035).
However, no such differences were observed when PCR-
based parasite prevalence data were compared in a similar
way (Figure 5B).
Discussion
The presented surveys revealed surprisingly low levels of
microscopically detectable malaria parasite prevalence at
all study sites. Although direct comparison to previous
studies is considerably limited by differences in study
design (e.g. age groups surveyed) and the fact that surveys
were carried out at different months of the year (shortly
after the end of the transmission season versus peak of
transmission season) and in different villages, the parasite
prevalence values reported here are amongst the lowest
published, remaining below the level reported from sur-
veys carried out at the end of the non-transmission sea-
son. The data presented are thus in line with the decline in
disease burden documented previously for the Gambia
[1]. The renewed efforts to eradicate malaria [39], require
surveillance systems that strive to identify the last parasite
carriers. The usefulness of PCR, RDT and serology was,
therefore, explored as techniques for surveillance.
Not surprisingly, the RDT, having a sensitivity threshold
of around 500 parasites/μl, which is designed to detect
clinical malaria, proved unsuitable to identify parasite car-
riers in this low transmission setting, where the geometric
mean parasite density, amongst those with microscopi-
cally detectable parasitaemia, was as low as 104 parasites/
μl (CI 95%: 76 - 143).
Thick film slide microscopy, still considered as the diag-
nostic gold standard for malaria, missed out 66% of para-
site carriers identified by nested PCR that has a detection
limit of ~1 to 10 parasites/μl [13,14]. This is in line with a
recently published meta-analysis on studies comparing
PCR and microscopy for malaria diagnosis in population
surveys [15]. This paper further documents, that the pro-
portion of infections missed by microscopy may increase
up to 88% where PCR prevalence declines to 10%.
Table 1: Parasite prevalence detected by PCR
Qualitative PCR
positives Total % positives 95% CI
Basse 219 841 26.0 23.2 - 29.0
Farafenni 185 689 26.9 23.7 - 30.3
Caio 194 818 23.7 20.9 - 26.7
all sites 598 2348 25.5 23.7 - 27.3
Table 2: Parasite prevalence detected by RDT
Rapid diagnostic test
positives Total % positives 95% CI
Basse 4 959 0.4 0.2 - 1.1
Farafenni 22 745 3.0 2.0 - 4.4
Caio 2 875 0.2 0.1 - 0.8
all sites 28 2579 1.1 0.8 - 1.6
Table 3: Parasite prevalence detected by slide microscopy
Slide microscopy
positives Total % positives 95% CI
Basse 97 934 10.4 8.6-12.5
Farafenni 82 729 11.2 9.2-13.7
Caio 33 834 4 2.8-5.5
all sites 212 2497 8.5 7.5-9.6Malaria Journal 2009, 8:274 http://www.malariajournal.com/content/8/1/274
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Clearly, the considerable number of individuals with low
density parasitaemia missed by microscopy constitutes a
major challenge for a malaria surveillance system: given
that gametocyte prevalence amongst parasite carriers may
be as high as 90% when assessed by Pfs25 QT-NASBA
[40], and that even artemisinin-based combination ther-
apy fails to completely abrogate post-treatment infec-
tiousness [40,41], the accurate identification of
individuals carrying parasites below the threshold for
slide microscopy is necessary to determine the remaining
potential for malaria transmission in a community. Here,
highly sensitive techniques such as PCR will become
indispensable.
The decline in burden of disease documented previously
[1], and the reduced parasite prevalence described here
occurred after renewed efforts to combat malaria in the
Gambia in 2004, such as more efficacious first-line treat-
ment [42], campaigns to retreat bed nets and ITN distribu-
tion in the Western Health Region. However, the
temporal association between the observed decline and
major control interventions does not necessarily prove a
causal relationship. In fact, a longitudinal study from
Kenya documented a substantial decline in malaria mor-
bidity and mortality even prior to large scale implementa-
tion of control measures [3].
Continuous increase of MSP-119 antibody sero-prevalence with age Figure 2
Continuous increase of MSP-119 antibody sero-prevalence with age. A-C) For each site the sero-prevalence of anti-
MSP-119 antibodies is shown according to age. Triangles represent the observed values, the continuous line shows the values 
predicted by the catalytic conversion model [17] with 95%
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To assess whether interventions had a sustained impact,
surveillance should therefore be able to capture long and
mid-term trends of transmission too, which could be
achieved by age profiles of anti -malarial antibody preva-
lence [17,19]. A successful intervention to control malaria
might be expected to result in a distinct "step" in the curve
describing the relationship between sero-prevalence and
age [18,43], with significantly lower levels of antibodies
in individuals born since the introduction of the control
measures. To explore whether such a step in the sero-prev-
alence profile of MSP-119 antibodies was evident, both
models with a fixed N [17] (force of infection), and "step
models" where N was allowed to vary at one point [19]
were fitted. For all sites, the models using a single N gave
the best fit, suggesting the decline in transmission is likely
to have occurred gradually over several years, and the EIR
reduction from 4 to 1 over the last 20 observed here for
Farafenni supports this. Further examination on the
nature of the gradual decline in transmission using a
steady reduction in N did not provide outcomes with a sig-
nificantly better fit. Further work is needed to define if the
existing data are sufficiently robust to allow fitting a vari-
able force of infection and how the decline in the force of
infection is best parameterized.
Variability of parasite -- and sero-prevalence is greatest within study sites Figure 3
Variability of parasite -- and sero-prevalence is greatest within study sites. The prevalence of P. falciparum parasitae-
mia as assessed by A) slide microscopy, or B) by PCR and the C) sero-prevalence of anti MSP-119 antibodies measured by 
ELISA as well as D) the percentage of children aged 1 to 15 years with a palpable spleen is shown for individual villages at each 
study site (Basse, Farafenni and Caio). Bars show percentages with 95%
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Considering that the Gambian study sites were outside the
areas targeted for ITN distribution in 2004, this is plausi-
ble and is supported by Multiple Indicator Cluster Survey
(MICS) data available for 2000 [44] and 2005/6 [45] in
which questionnaire-based data indicated that the pro-
portion of children < 5 sleeping under an ITN has
increased from 13.3% to 44.8% in an area prioritized for
ITN distribution (Brikama), whereas it only increased
from 14.7% to 16.8% in the Basse area, where parts of this
survey were carried out. In areas where malaria transmis-
sion is highly seasonal, serology offers the advantage of
being considerably less dependent of the timing of the
survey than direct assessment of parasite burden by PCR
or microscopy that can only provide a snapshot.
Regardless of the method used (slide microscopy, PCR or
serology), significant variability of parasite (or sero)-prev-
alence amongst villages of the same site were observed,
whereas the variability between sites did not differ signif-
icantly. This remained true even after adjusting for the
potentially confounding effects of bed net use and ethnic-
ity, suggesting that other factors may contribute to the var-
iability.
The difference in the distance to malaria breeding sites
that has been identified previously as a risk factor for
malaria in the Gambia [28], as well as the considerable
local variation in both malaria vector density [46] and
vector persistence [47] may account for some of the
remaining inter-village variability. Serology was equally
good at detecting the inter-village variability observed by
PCR or microscopy. Considering that sero-prevalence is a
cumulative measure of exposure over time and less sus-
ceptible to transient fluctuations, the inter-village differ-
ences described here may indeed reflect a relatively stable
pattern. Where complete data are available (Basse, Caio),
this notion is further supported by the distribution of
spleen rates in 1-15 year old children (Figure 3D).
In view of the planned malaria elimination efforts that
will require adequate surveillance, the spatial heterogene-
ity of malaria transmission observed locally also consti-
Peak of parasite prevalence shifts to adolescence Figure 4
Peak of parasite prevalence shifts to adolescence. Parasite prevalence assessed by A) PCR or B) slide microscopy is 
shown, stratified by age group, showing a significant linear increase from 0-15 years (p < 0.0001 [PCR]; p = 0.003 [slide]). In B) 
geometric mean parasite densities are added for each age group, showing a significant decline from 0-15 years p < 0.0001), 
remaining stable thereafter (p = 0.3). Plot C) shows age-stratified parasite prevalence as determined in October 1988 [38] 
from a village in the Farafenni area. D) Corresponding data from the Farafenni area (villages "D" "L" "S" and "W") from the sur-
vey in January 2008 (described in this paper) are shown. Bars show percentages with 95% CI.
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tutes a considerable challenge as it renders the
identification of a sentinel village that ought to be repre-
sentative for surveillance purposes of a larger area diffi-
cult. Alternative approaches, such as surveys carried out in
schools and/or at health facilities which combine PCR/
serology with geographic information (GIS) will become
invaluable to identify remaining foci of transmission.
Compared to previous reports, a shift of peak parasite
prevalence (both by PCR and slide reading) towards the
group of 11-15 years old was observed. This is in sharp
contrast to a survey carried out in rural Gambia in the dry
season of 1950 where over 95% of children < 5 years and
89% of children aged 6-10 years were found to be parasi-
taemic [48]. Still in October 1988, parasitaemia rates doc-
umented for a village in the Farafenni area remained
constantly above 60% until the age of 15 years [38].
While age prevalence profiles of malaria parasitaemia may
shift to older age groups with decreasing transmission
regardless of its cause, the most obvious reason in our
study area probably is the comparably high level of bed
net usage in children < 5 years in the Gambia, currently
being amongst the countries with the highest coverage of
ITNs in children < 5 [49]. As expected, overall bed net-
usage had a protective effect with regard to microscopic
parasite prevalence. Especially children up to 10 years not
using bed nets had significantly higher parasite preva-
lence. However, no such difference was observed when
parasite prevalence was measured by PCR, confirming
that bed nets may reduce but not entirely abrogate expo-
sure to malaria. The remaining low level exposure result-
ing in submicroscopic infections among bed net users
may also explain that, with the exception of those < 5
years old, anti-malarial antibodies develop at similar rates
regardless whether or not a bed net is used. The notion
that anti-malarial immunity can develop despite bed net-
usage is consistent with results from longitudinal studies
demonstrating that introduction of ITNs [50] or insecti-
cide-treated curtains [51] does not increase child mortal-
ity in older children. However, the age shift for peak
parasite prevalence also means that acquisition of protec-
tive immunity may occur later, which finds its expression
in an increased mean age of paediatric malaria admissions
[1] - an observation that points out the need to review cur-
rent guidelines on the management of childhood illness
for areas of low malaria prevalence, as these guidelines
focus on children below five years [52].
Conclusion
In summary, the data presented here suggest that particu-
larly in areas of declining malaria prevalence efficient sur-
veillance requires methods able to reliably identify sub-
microscopic levels of parasitaemia in order to identify
remaining foci of transmission for targeted interventions.
Where malaria eradication is the aim the considerable var-
iability in malaria prevalence observed in a confined
space calls out for a rather dense network of sentinel sites
or alternative approaches. This will require highly sensi-
tive, high throughput techniques such as PCR that show
promise even on non-invasive samples [14]. PCR would
be well complemented by serological assessment, to ade-
quately capture the current situation on a population
level, and also provide information on changes in trans-
mission over time, and a parametric estimation of the
entomological inoculation rate [18]. Field samples for
both PCR and ELISA can be collected onto filter paper
Bed net use in under 5 year olds reduces parasite prevalence  measured by slide but not by PCR Figure 5
Bed net use in under 5 year olds reduces parasite 
prevalence measured by slide but not by PCR. Age-
stratified parasite prevalence assessed by A) slide microscopy 
or B) PCR, and C) MSP-119 antibody sero-prevalence for indi-
viduals sleeping under bed nets (open bars) or not (hatched 
bars) are shown. Bars represent percentages with 95% CI.
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[53], and processed in moderate- to high-throughput
assays, where the relevant laboratory equipment is availa-
ble.
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